Daniel Patrick O'Day - 10 Mar 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chairman & CEO, Director
Signature
/s/ Amy Kim by Power of Attorney for Daniel O'Day
Issuer symbol
GILD
Transactions as of
10 Mar 2023
Net transactions value
-$1,114,352
Form type
4
Filing time
14 Mar 2023, 12:03:01 UTC
Previous filing
02 Mar 2023
Next filing
12 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +19,488 +5.4% 378,983 10 Mar 2023 Direct F1
transaction GILD Common Stock Options Exercise +10,800 +2.8% 389,783 10 Mar 2023 Direct F1
transaction GILD Common Stock Tax liability $1,114,352 -14,017 -3.6% $79.50 375,766 10 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -19,488 -17% 96,563 10 Mar 2023 Common Stock 19,488 Direct F1, F2
transaction GILD Restricted Stock Unit Options Exercise -10,800 -11% 85,763 10 Mar 2023 Common Stock 10,800 Direct F1, F3
transaction GILD Restricted Stock Unit Award +47,170 +55% 132,933 10 Mar 2023 Common Stock 47,170 Direct F1, F2
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +215,095 $0.000000 215,095 10 Mar 2023 Common Stock 215,095 $79.50 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3 The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
F4 The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.